Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children: a randomized controlled trial in Burkina Faso.

MLA

Coulibaly, Boubacar, et al. “Efficacy and Safety of Triple Combination Therapy with Artesunate-Amodiaquine-Methylene Blue for Falciparum Malaria in Children: A Randomized Controlled Trial in Burkina Faso.” The Journal of Infectious Diseases, vol. 211, no. 5, Mar. 2015, pp. 689–97. EBSCOhost, https://doi.org/10.1093/infdis/jiu540.

APA

Coulibaly, B., Pritsch, M., Bountogo, M., Meissner, P. E., Nebié, E., Klose, C., Kieser, M., Berens-Riha, N., Wieser, A., Sirima, S. B., Breitkreutz, J., Schirmer, R. H., Sié, A., Mockenhaupt, F. P., Drakeley, C., Bousema, T., & Müller, O. (2015). Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children: a randomized controlled trial in Burkina Faso. The Journal of Infectious Diseases, 211(5), 689–697. https://doi.org/10.1093/infdis/jiu540

Chicago

Coulibaly, Boubacar, Michael Pritsch, Mamadou Bountogo, Peter E Meissner, Eric Nebié, Christina Klose, Meinhard Kieser, et al. 2015. “Efficacy and Safety of Triple Combination Therapy with Artesunate-Amodiaquine-Methylene Blue for Falciparum Malaria in Children: A Randomized Controlled Trial in Burkina Faso.” The Journal of Infectious Diseases 211 (5): 689–97. doi:10.1093/infdis/jiu540.